• Are between the ages of 21 and 45.
• Are
nearsighted with or without
astigmatism or
farsighted, including those with mild, moderate, and severe myopia (as low as -3D to as high as -20D prescription) with minor or no occurrence of astigmatism. The Visian Toric ICL™, capable of correcting myopia with astigmatism, is currently under review with the U.S. FDA. The Visian TICL™ is currently available only outside of the United States.
• Have sufficient anterior chamber depth and acceptable endothelial cell density (this will be determined after a comprehensive eye exam).
• Have not had a change in their eyeglass prescription of more than 0.5D in a year.
• Are not currently pregnant.
• Have no other contraindications including no known allergies to medications used during refractive surgery.
• Have dry eyes, severe myopia, or a thin cornea (non-LASIK candidate).